Table 4.
PERG | All patients | Control values | p-values | Group 1a | Control values | p-values | 95%CI | ||
---|---|---|---|---|---|---|---|---|---|
P50 | Amplitude (μV) | RE | 4.32 ± 1.51 | 4.92 ± 1.66 | 4.92 ± 1.66 | 3.13 ± 0.67 | 4.92 ± 1.66 | 0.0014 | [0.76 to 2.81] |
LE | 4.35 ± 1.78 | 4.58 ± 0.91 | 4.58 ± 0.91 | 2.93 ± 0.81 | 4.58 ± 0.91 | 0.0232 | [0.21 to 2.61] | ||
N95 | Amplitude (μV) | RE | −5.90 ± .293 | − 6.65 ± 2.06 | −6.65 ± 2.06 | −4.00 ± 0.84 | −6.65 ± 2.06 | 0.0006 | [−4.01 to 1.27] |
LE | −5.19 ± .460 | −5.65 ± 1.63 | −5.65 ± 1.63 | −3.19 ± 0.94 | −5.65 ± 1.63 | 0.0002 | [−3.60 to 1.31] |
Data are presented as mean ± SD or as numbers. Amp amplitude, PERG pattern electroretinogram, CI confidence interval, μV microvolts, RE right eye, LE left eye
aGroup 1 is a subgroup of patients with evident visual disturbances in their visual field test. Patients with concentric constriction (17 eyes) and hemi-field defects (5 eyes) patterns